Patents Assigned to Celerant Therapeutics, Inc.
  • Methods of expanding myeloid cell populations and uses thereof
    Patent number: 8252587
    Abstract: The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: August 28, 2012
    Assignee: Celerant Therapeutics, Inc.
    Inventors: Timothy C. Fong, Adrianus Geertrudis Wilhelmus Domen, Julie Lynne Christensen